1.79
price up icon4.68%   0.08
after-market After Hours: 1.75 -0.04 -2.23%
loading
Fortress Biotech Inc stock is traded at $1.79, with a volume of 330.69K. It is up +4.68% in the last 24 hours and up +0.56% over the past month. Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology and therapeutics sectors.
See More
Previous Close:
$1.71
Open:
$1.71
24h Volume:
330.69K
Relative Volume:
1.56
Market Cap:
$62.10M
Revenue:
$80.97M
Net Income/Loss:
$-78.31M
P/E Ratio:
-0.1615
EPS:
-11.0849
Net Cash Flow:
$-129.56M
1W Performance:
-2.19%
1M Performance:
+0.56%
6M Performance:
-1.10%
1Y Performance:
+5.29%
1-Day Range:
Value
$1.71
$1.82
1-Week Range:
Value
$1.70
$1.87
52-Week Range:
Value
$1.325
$2.89

Fortress Biotech Inc Stock (FBIO) Company Profile

Name
Name
Fortress Biotech Inc
Name
Phone
781-652-4500
Name
Address
1111 KANE CONCOURSE, BAY HARBOR ISLANDS, NY
Name
Employee
101
Name
Twitter
@fortressbio
Name
Next Earnings Date
2024-11-12
Name
Latest SEC Filings
Name
FBIO's Discussions on Twitter

Compare FBIO with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
FBIO
Fortress Biotech Inc
1.79 62.10M 80.97M -78.31M -129.56M -11.08
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
450.27 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
522.27 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
325.00 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
568.06 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
266.80 28.51B 3.81B -644.79M -669.77M -6.24

Fortress Biotech Inc Stock (FBIO) Upgrades & Downgrades

Date Action Analyst Rating Change
Mar-15-24 Resumed ROTH MKM Buy
Aug-04-22 Initiated Ladenburg Thalmann Buy
Oct-02-20 Initiated The Benchmark Company Buy
Dec-18-19 Initiated B. Riley FBR Buy
Feb-28-18 Initiated B. Riley FBR, Inc. Buy
Jul-11-17 Initiated Rodman & Renshaw Buy
Mar-22-17 Initiated JMP Securities Mkt Outperform
Oct-03-16 Initiated ROTH Capital Buy
View All

Fortress Biotech Inc Stock (FBIO) Latest News

pulisher
Jun 14, 2025

How To Trade (FBIOP) - news.stocktradersdaily.com

Jun 14, 2025
pulisher
Jun 13, 2025

Two Sigma Investments LP Invests $109,000 in Fortress Biotech, Inc. (NASDAQ:FBIO) - Defense World

Jun 13, 2025
pulisher
Jun 09, 2025

Journey Medical Corporation Announces Emrosi™ Featured on “The Balancing Act” Airing on Lifetime TV - GlobeNewswire

Jun 09, 2025
pulisher
Jun 09, 2025

Jane Street Group LLC Takes Position in Fortress Biotech, Inc. (NASDAQ:FBIO) - Defense World

Jun 09, 2025
pulisher
Jun 05, 2025

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Fortress Biotech, Inc. of Class Action Lawsuit and Upcoming Deadline – FBIO - ACCESS Newswire

Jun 05, 2025
pulisher
Jun 03, 2025

Fortress Biotech (FBIO) Is Attractively Priced Despite Fast-paced Momentum - Yahoo Finance

Jun 03, 2025
pulisher
Jun 01, 2025

Checkpoint Therapeutics, Inc.(NasdaqCM: CKPT) dropped from S&P TMI Index - marketscreener.com

Jun 01, 2025
pulisher
May 30, 2025

Fortress Biotech Announces Closing of Sale of Subsidiary Checkpo - GuruFocus

May 30, 2025
pulisher
May 30, 2025

Fortress Biotech Announces Sale of Subsidiary Checkpoint Therapeutics - citybiz

May 30, 2025
pulisher
May 30, 2025

Sun Pharmaceutical Industries Completes Acquisition Of Checkpoint Therapeutics - marketscreener.com

May 30, 2025
pulisher
May 30, 2025

Fortress Biotech Closes Sale of Checkpoint Therapeutics Unit - marketscreener.com

May 30, 2025
pulisher
May 30, 2025

Fortress Biotech Announces Closing of Sale of Subsidiary Checkpoint Therapeutics | FBIO Stock News - GuruFocus

May 30, 2025
pulisher
May 30, 2025

Fortress Biotech Announces Closing of Sale of Subsidiary Checkpoint Therapeutics - GlobeNewswire

May 30, 2025
pulisher
May 30, 2025

Fortress Biotech, Inc. Announces Acquisition of Checkpoint Therapeutics by Sun Pharmaceutical Industries Limited - Nasdaq

May 30, 2025
pulisher
May 30, 2025

Fortress Biotech Announces Closing of Sale of Subsidiary Checkpoint Therapeutics - Benzinga

May 30, 2025
pulisher
May 29, 2025

Checkpoint Therapeutics shareholders approve Sun Pharma merger By Investing.com - Investing.com India

May 29, 2025
pulisher
May 29, 2025

One Fortress Biotech Insider Raised Stake By 26% In Previous Year - simplywall.st

May 29, 2025
pulisher
May 28, 2025

Checkpoint Investor Sues for Info on Sale From Fortress to Sun - Bloomberg Law News

May 28, 2025
pulisher
May 27, 2025

New Strong Sell Stocks for May 16th - The Globe and Mail

May 27, 2025
pulisher
May 23, 2025

Q2 EPS Estimates for Fortress Biotech Raised by Roth Capital - Defense World

May 23, 2025
pulisher
May 22, 2025

How the (FBIOP) price action is used to our Advantage - news.stocktradersdaily.com

May 22, 2025
pulisher
May 22, 2025

Sun Pharma Q4 Consol Net PAT 21.5 Billion Rupees - marketscreener.com

May 22, 2025
pulisher
May 20, 2025

Fortress Biotech Reports Q1 2025 Financial Highlights - TipRanks

May 20, 2025
pulisher
May 17, 2025

Fortress Biotech First Quarter 2025 Earnings: Beats Expectations - Yahoo Finance

May 17, 2025
pulisher
May 16, 2025

Fortress Biotech Inc (FBIO) Reports Q1 2025 Revenue of $13.1M, S - GuruFocus

May 16, 2025
pulisher
May 16, 2025

Fortress Biotech: Q1 Earnings Snapshot - CT Insider

May 16, 2025
pulisher
May 15, 2025

Fortress Biotech (FBIO) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance

May 15, 2025
pulisher
May 15, 2025

Fortress Biotech, Inc. SEC 10-Q Report - TradingView

May 15, 2025
pulisher
May 15, 2025

Fortress Biotech Inc (FBIO) Reports Q1 2025 Revenue of $13.1M, Surpassing Estimates - GuruFocus

May 15, 2025
pulisher
May 15, 2025

Fortress Biotech Reports First Quarter 2025 Financial Results an - GuruFocus

May 15, 2025
pulisher
May 15, 2025

Fortress Biotech Reports First Quarter 2025 Financial Results and Recent Corporate Highlights - GlobeNewswire

May 15, 2025
pulisher
May 15, 2025

Fortress Biotech Earnings: Triple Win with $28M Checkpoint Deal, FDA Fast-Track, and Rosacea Drug Launch - Stock Titan

May 15, 2025
pulisher
May 14, 2025

Journey Medical Corporation Reports First Quarter 2025 Financial Results and Recent Corporate Highlights - GlobeNewswire

May 14, 2025
pulisher
May 14, 2025

Fortress Biotech (FBIO) Projected to Post Quarterly Earnings on Wednesday - Defense World

May 14, 2025
pulisher
May 13, 2025

Checkpoint Therapeutics Reports First Quarter Financial Results and Recent Corporate Updates - GlobeNewswire

May 13, 2025
pulisher
May 12, 2025

INDIA STOCKS-Indian benchmarks jump 2.5% as India-Pakistan truce fuels relief rally - marketscreener.com

May 12, 2025
pulisher
May 07, 2025

Fortress Biotech to Participate in the H.C. Wainwright 1st Annual Royalty Company Virtual Conference | FBIO Stock News - GuruFocus

May 07, 2025
pulisher
May 07, 2025

Fortress Biotech to Participate in the H.C. Wainwright 1st Annual Royalty Company Virtual Conference - The Manila Times

May 07, 2025
pulisher
May 05, 2025

Renaissance Technologies LLC Has $356,000 Stock Holdings in Fortress Biotech, Inc. (NASDAQ:FBIO) - Defense World

May 05, 2025
pulisher
May 05, 2025

Fortress Biotech, Inc. (NASDAQ:FBIO) Stock Position Boosted by Envestnet Asset Management Inc. - Defense World

May 05, 2025
pulisher
May 03, 2025

Geode Capital Management LLC Increases Stock Position in Fortress Biotech, Inc. (NASDAQ:FBIO) - Defense World

May 03, 2025
pulisher
Apr 28, 2025

Fortress Biotech and Cyprium Therapeutics Announce U.S. FDA Acceptance and Priority Review of NDA for CUTX-101 for Treatment of Menkes Disease - The Globe and Mail

Apr 28, 2025
pulisher
Apr 22, 2025

Fortress Biotech Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights - ADVFN

Apr 22, 2025
pulisher
Apr 21, 2025

Sun Pharma shares in focus as co to acquire Checkpoint Therapeutics for $355 million - MSN

Apr 21, 2025
pulisher
Apr 16, 2025

Fortress Biotech Board Member Resigns for New Role - TipRanks

Apr 16, 2025
pulisher
Apr 16, 2025

When the Price of (FBIOP) Talks, People Listen - news.stocktradersdaily.com

Apr 16, 2025
pulisher
Apr 15, 2025

Fortress Biotech (NASDAQ:FBIOP) Trading Down 2.1% – What’s Next? - Defense World

Apr 15, 2025
pulisher
Apr 09, 2025

This Fortress Biotech Insider Increased Their Holding By 26% Last Year - Yahoo Finance

Apr 09, 2025

Fortress Biotech Inc Stock (FBIO) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Fortress Biotech Inc Stock (FBIO) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
ROSENWALD LINDSAY A MD
PRESIDENT, CEO & CHAIRMAN
Sep 23 '24
Buy
1.84
763,359
1,404,581
3,657,264
ROSENWALD LINDSAY A MD
President, CEO & Chairman
Jul 11 '24
Buy
7.48
5,000
37,418
127,500
Jin David
Chief Financial Officer
Jul 10 '24
Buy
7.50
500
3,750
500
ROSENWALD LINDSAY A MD
President, CEO & Chairman
Jul 09 '24
Buy
7.39
5,000
36,971
122,500
ROSENWALD LINDSAY A MD
President, CEO & Chairman
Jul 08 '24
Buy
7.35
5,000
36,764
117,500
ROSENWALD LINDSAY A MD
President, CEO & Chairman
Jun 28 '24
Buy
1.64
20,000
32,724
2,893,905
$20.74
price up icon 0.29%
$36.14
price up icon 2.09%
$20.92
price up icon 2.60%
$105.90
price up icon 0.46%
$105.09
price up icon 2.02%
biotechnology ONC
$266.80
price up icon 3.61%
Cap:     |  Volume (24h):